Literature DB >> 22581377

Stimulus chromatic properties affect period doubling in the human cone flicker ERG.

Sowjanya Gowrisankaran1, Kenneth R Alexander.   

Abstract

Period doubling in the full-field cone flicker electroretinogram (ERG) refers to an alternation in waveform amplitude and/or shape from cycle to cycle, presumably owing to the operation of a nonlinear gain control mechanism. This study examined the influence of stimulus chromatic properties on the characteristics of period doubling in order to better understand the underlying mechanism. ERGs were acquired from 5 visually normal subjects in response to sinusoidally modulated flicker presented at frequencies from 25 to 100 Hz. The test stimuli and the pre-stimulus adaptation were either long wavelength (R), middle wavelength (G), or an equal combination of long and middle wavelengths (Y), all equated for photopic luminance. Fourier analysis was used to obtain the response amplitude at the stimulus frequency F and at a harmonic frequency of 3F/2, which was used as the index of period doubling. The frequency-response function for 3F/2 typically showed two peaks, occurring at approximately 33.3 and 50 Hz. However, the magnitude of period doubling within these frequency regions was dependent on the chromatic properties of both the test stimulus and the pre-stimulus adaptation. Period doubling was generally smallest when an R test was used, even though the stimuli were luminance-equated and the amplitude of F did not differ between the various conditions. The pattern of results indicates that the mechanism that generates period doubling is influenced by chromatic signals from both the test stimulus and the pre-stimulus adaptation, even though the high stimulus frequencies presumably favor the achromatic luminance system.

Entities:  

Mesh:

Year:  2012        PMID: 22581377      PMCID: PMC3402583          DOI: 10.1007/s10633-012-9326-1

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  22 in total

1.  Cone selective adaptation influences L- and M-cone driven signals in electroretinography and psychophysics.

Authors:  Jan Kremers; Maciej W Stepien; Hendrik P N Scholl; Cézar Saito
Journal:  J Vis       Date:  2003       Impact factor: 2.240

2.  Effect of contrast on the frequency response of synchronous period doubling.

Authors:  Kenneth R Alexander; Aparna Raghuram
Journal:  Vision Res       Date:  2006-10-30       Impact factor: 1.886

3.  Characteristics of period doubling in the human cone flicker electroretinogram.

Authors:  Kenneth R Alexander; Michael W Levine; Boaz J Super
Journal:  Vis Neurosci       Date:  2005 Nov-Dec       Impact factor: 3.241

4.  Comparison of spectral measures of period doubling in the cone flicker electroretinogram.

Authors:  Kenneth R Alexander; Aparna Raghuram; J Jason McAnany
Journal:  Doc Ophthalmol       Date:  2008-03-21       Impact factor: 2.379

5.  ISCEV Standard for full-field clinical electroretinography (2008 update).

Authors:  M F Marmor; A B Fulton; G E Holder; Y Miyake; M Brigell; M Bach
Journal:  Doc Ophthalmol       Date:  2008-11-22       Impact factor: 2.379

6.  Synchronous period-doubling in flicker vision of salamander and man.

Authors:  D W Crevier; M Meister
Journal:  J Neurophysiol       Date:  1998-04       Impact factor: 2.714

7.  The chromatic input to cells of the magnocellular pathway of primates.

Authors:  Barry B Lee; Hao Sun
Journal:  J Vis       Date:  2009-02-12       Impact factor: 2.240

8.  Sophisticated temporal pattern recognition in retinal ganglion cells.

Authors:  Greg Schwartz; Michael J Berry
Journal:  J Neurophysiol       Date:  2008-02-13       Impact factor: 2.714

9.  Characteristics of period doubling in the rat cone flicker ERG.

Authors:  Manthan R Shah; Kenneth R Alexander; Harris Ripps; Haohua Qian
Journal:  Exp Eye Res       Date:  2009-10-17       Impact factor: 3.467

10.  Flicker ERGs representing chromaticity and luminance signals.

Authors:  Jan Kremers; Anderson Raiol Rodrigues; Luiz Carlos de Lima Silveira; Manoel da Silva Filho
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.